Duality Advisers’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-19,131
Closed -$3.28M 406
2024
Q1
$3.28M Buy
19,131
+9,029
+89% +$1.68M 0.32% 96
2023
Q4
$2.19M Buy
10,102
+1,387
+16% +$238K 0.23% 154
2023
Q3
$1.39M Sell
8,715
-6,390
-42% -$1.43M 0.17% 225
2023
Q2
$4.36M Buy
15,105
+13,799
+1,057% +$4.19M 0.55% 25
2023
Q1
$417K Buy
1,306
+356
+37% +$106K 0.05% 442
2022
Q4
$280K Buy
+950
New +$262K 0.03% 528
2022
Q2
Sell
-3,763
Closed -$1M 811
2022
Q1
$1M Buy
3,763
+1,371
+57% +$336K 0.11% 317
2021
Q4
$636K Buy
+2,392
New +$694K 0.07% 375
2021
Q3
Sell
-6,876
Closed -$1.89M 672
2021
Q2
$1.89M Buy
+6,876
New +$1.87M 0.17% 212
2021
Q1
Sell
-9,239
Closed -$2.36M 667
2020
Q4
$2.36M Buy
+9,239
New +$2.29M 0.18% 179

Other funds holding PODD

Duality Advisers's PODD Position: Q2 2024 in Review

Duality Advisers sold out of Insulet (PODD) in Q2 2024, closing a stake of 19,131 shares — an estimated $3.28M sold.

Duality Advisers first reported a position in PODD in Q4 2020 and held it in 10 quarters. The position peaked at $4.36M in Q2 2023. 598 funds tracked by Wall St. Rank hold PODD as of Q2 2024.

  • Duality Advisers reported no remaining Insulet position as of Q2 2024 after selling out during the quarter.
  • Duality Advisers sold 19,131 Insulet shares in Q2 2024, an estimated $3.28M.
  • Duality Advisers first reported a position in Insulet in Q4 2020 and held it in 10 quarters.
  • Duality Advisers's Insulet position peaked at $4.36M in Q2 2023.
  • 598 funds tracked by Wall St. Rank held Insulet as of Q2 2024.

Based on Duality Advisers's 13F filing for Q2 2024.